메뉴 건너뛰기




Volumn 117, Issue 8, 2011, Pages 2300-2302

MEK and MAF in myeloma therapy

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; DEXAMETHASONE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; THALIDOMIDE;

EID: 79952142407     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-01-327262     Document Type: Note
Times cited : (11)

References (9)
  • 1
    • 79952123613 scopus 로고    scopus 로고
    • A mechanistic rationale forMEKinhibitor therapy in myeloma based on blockade ofMAFoncogene expression
    • Annunziata CM, Hernandez L, Davis RE, et al. A mechanistic rationale forMEKinhibitor therapy in myeloma based on blockade ofMAFoncogene expression. Blood. 2011;117(8):2396-2404.
    • (2011) Blood , vol.117 , Issue.8 , pp. 2396-2404
    • Annunziata, C.M.1    Hernandez, L.2    Davis, R.E.3
  • 2
    • 33745779502 scopus 로고    scopus 로고
    • The molecular classification of multiple myeloma
    • Zhan F, Huang Y, Colla S, et al. The molecular classification of multiple myeloma. Blood. 2006;108(6):2020-2028.
    • (2006) Blood , vol.108 , Issue.6 , pp. 2020-2028
    • Zhan, F.1    Huang, Y.2    Colla, S.3
  • 3
    • 1442285889 scopus 로고    scopus 로고
    • Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma
    • DOI 10.1016/S1535-6108(04)00019-4, PII S1535610804000194
    • Hurt EM, Wiestner A, Rosenwald A, et al. Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma. Cancer Cell. 2004;5(2): 191-199. (Pubitemid 38283804)
    • (2004) Cancer Cell , vol.5 , Issue.2 , pp. 191-199
    • Hurt, E.M.1    Wiestner, A.2    Rosenwald, A.3    Shaffer, A.L.4    Campo, E.5    Grogan, T.6    Bergsagel, P.L.7    Kuehl, W.M.8    Staudt, L.M.9
  • 4
    • 78650978001 scopus 로고    scopus 로고
    • The MMSEThistone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells
    • Martinez-Garcia E, Popovic R, Min DJ, et al. The MMSEThistone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells. Blood. 2011;117(1):211-220.
    • (2011) Blood , vol.117 , Issue.1 , pp. 211-220
    • Martinez-Garcia, E.1    Popovic, R.2    Min, D.J.3
  • 5
    • 58149232433 scopus 로고    scopus 로고
    • MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cells
    • Brito JL, Walker B, Jenner M, et al.MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cells. Haematologica. 2009;94(1): 78-86.
    • (2009) Haematologica , vol.94 , Issue.1 , pp. 78-86
    • Brito, J.L.1    Walker, B.2    Jenner, M.3
  • 6
    • 38349087546 scopus 로고    scopus 로고
    • The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity
    • Lauring J, Abukhdeir AM, Konishi H, et al. The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity. Blood. 2008;111(2):856-864.
    • (2008) Blood , vol.111 , Issue.2 , pp. 856-864
    • Lauring, J.1    Abukhdeir, A.M.2    Konishi, H.3
  • 9
    • 77957738022 scopus 로고    scopus 로고
    • Impressions of the myeloma landscape
    • Bergsagel PL. Impressions of the myeloma landscape. Blood. 2010;116(14):2403-2404.
    • (2010) Blood , vol.116 , Issue.14 , pp. 2403-2404
    • Bergsagel, P.L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.